Wisconsin Mesothelioma Doctors, Cancer Centers and Treatment

People diagnosed with mesothelioma who live in Wisconsin have access to a number of quality health care options. Conventional mesothelioma treatments available in Wisconsin include surgery, chemotherapy and radiation. Beyond these conventional treatments, clinical trials may currently be recruiting pleural and peritoneal mesothelioma patients. Experimental and alternative treatments may also be available.

We have listed top mesothelioma doctors who practice in Wisconsin as well as the top cancer care centers in the state. A number of local cancer support services have been included as well for your convenience. Read more about health care options available in Wisconsin below.

Mesothelioma Cancer Centers in Wisconsin

For your convenience, we have compiled a list of mesothelioma cancer centers that are located in Wisconsin. Please click on a cancer center link to obtain more information about the clinical programs offered and how to contact the cancer center.

Find a Mesothelioma Doctor in Wisconsin

The following mesothelioma doctors are located and practice in the state of Wisconsin. Click on the doctor’s name to obtain more information about their background, areas of expertise, professional affiliations, and office locations.

Occasionally, mesothelioma patients will travel to other states to meet with top mesothelioma doctors and thoracic surgeons across the country. These experts will usually concentrate on a particular mesothelioma type within their practice.

Mesothelioma Clinical Trials in Wisconsin

The following clinical trials are in progress or actively recruiting participants in the state of Wisconsin:

• Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

  Conditions:	Acinar Cell Carcinoma; Adenoid Cystic Carcinoma; Adrenal Cortex Carcinoma; Adrenal Gland Pheochromocytoma; Anal Canal Neuroendocrine Carcinoma; Anal Canal Undifferentiated Carcinoma; Angiosarcoma; Apocrine Neoplasm; Appendix Mucinous Adenocarcinoma; Bartholin Gland Transitional Cell Carcinoma; Basal Cell Carcinoma; Bladder Adenocarcinoma; Cervical Adenocarcinoma; Cervical Clear Cell Adenocarcinoma; Cholangiocarcinoma; Chordoma; Colorectal Squamous Cell Carcinoma; Desmoid-Type Fibromatosis; Endometrial Transitional Cell Carcinoma; Endometrioid Adenocarcinoma; Esophageal Neuroendocrine Carcinoma; Esophageal Undifferentiated Carcinoma; Extrahepatic Bile Duct Carcinoma; Extramammary Paget Disease; Fallopian Tube Adenocarcinoma; Fallopian Tube Transitional Cell Carcinoma; Fibromyxoid Tumor; Gallbladder Carcinoma; Gastric Neuroendocrine Carcinoma; Gastric Squamous Cell Carcinoma; Gastric Undifferentiated Carcinoma; Gastrointestinal Stromal Tumor; Gestational Trophoblastic Tumor; Giant Cell Carcinoma; Intestinal Neuroendocrine Carcinoma; Intrahepatic Cholangiocarcinoma; Lung Carcinoid Tumor; Lung Sarcomatoid Carcinoma; Major Salivary Gland Carcinoma; Malignant Odontogenic Neoplasm; Malignant Peripheral Nerve Sheath Tumor; Malignant Testicular Sex Cord-Stromal Tumor; Metaplastic Breast Carcinoma; Metastatic Malignant Neoplasm of Unknown Primary; Minimally Invasive Lung Adenocarcinoma; Mixed Mesodermal (Mullerian) Tumor; Mucinous Adenocarcinoma; Mucinous Cystadenocarcinoma; Nasal Cavity Adenocarcinoma; Nasal Cavity Carcinoma; Nasopharyngeal Carcinoma; Nasopharyngeal Papillary Adenocarcinoma; Nasopharyngeal Undifferentiated Carcinoma; Oral Cavity Carcinoma; Oropharyngeal Undifferentiated Carcinoma; Ovarian Adenocarcinoma; Ovarian Clear Cell Adenocarcinoma; Ovarian Germ Cell Tumor; Ovarian Mucinous Adenocarcinoma; Ovarian Squamous Cell Carcinoma; Ovarian Transitional Cell Carcinoma; Pancreatic Acinar Cell Carcinoma; Pancreatic Neuroendocrine Carcinoma; Paraganglioma; Paranasal Sinus Adenocarcinoma; Paranasal Sinus Carcinoma; Parathyroid Gland Carcinoma; PEComa; Peritoneal Mesothelioma; Pituitary Gland Carcinoma; Placental Choriocarcinoma; Primary Peritoneal High Grade Serous Adenocarcinoma; Pseudomyxoma Peritonei; Rare Disorder; Scrotal Squamous Cell Carcinoma; Seminal Vesicle Adenocarcinoma; Seminoma; Serous Cystadenocarcinoma; Small Intestinal Adenocarcinoma; Small Intestinal Squamous Cell Carcinoma; Solid Neoplasm; Spindle Cell Neoplasm; Squamous Cell Carcinoma of the Penis; Teratoma With Somatic-Type Malignancy; Testicular Non-Seminomatous Germ Cell Tumor; Thyroid Gland Carcinoma; Tracheal Carcinoma; Transitional Cell Carcinoma; Ureter Adenocarcinoma; Ureter Squamous Cell Carcinoma; Urethral Adenocarcinoma; Urethral Squamous Cell Carcinoma; Vaginal Adenocarcinoma; Vaginal Squamous Cell Carcinoma, Not Otherwise Specified; Vulvar Carcinoma
  Last Updated:	July 8, 2019
  Status:	Recruiting
  Locations:	Ashland, WI. Chippewa Falls, WI. Eau Claire, WI. Green Bay, WI. La Crosse, WI. Ladysmith, WI. Manitowoc, WI. Marinette, WI. Marshfield, WI. Minocqua, WI.

• Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma

  Conditions:	Mesothelioma; Pleural Mesothelioma
  Last Updated:	June 17, 2019
  Status:	Active, not recruiting
  Locations:	Wauwatosa, WI. La Jolla, CA. Los Angeles, CA. Stanford, CA. Aurora, CO. Miami, FL. Atlanta, GA. Chicago, IL. Evanston, IL. Baltimore, MD.

• Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin

  Conditions:	Advanced Malignant Solid Neoplasm; Advanced Peritoneal Malignant Mesothelioma; Advanced Pleural Malignant Mesothelioma; Recurrent Peritoneal Malignant Mesothelioma; Recurrent Pleural Malignant Mesothelioma; Refractory Malignant Solid Neoplasm; Unresectable Solid Neoplasm
  Last Updated:	June 10, 2019
  Status:	Recruiting
  Locations:	Madison, WI. Duarte, CA. Los Angeles, CA. Pasadena, CA. Sacramento, CA. Aurora, CO. Baltimore, MD. Ann Arbor, MI. Rochester, MN. Columbus, OH.

• Pemetrexed Disodium/Observation in Treating Patients W/ Malignant Pleural Mesothelioma w/Out Progressive Disease After 1st Line Chemotherapy

  Conditions:	Malignant Mesothelioma
  Last Updated:	March 4, 2019
  Status:	Active, not recruiting
  Locations:	La Crosse, WI. Scottsdale, AZ. San Francisco, CA. Hartford, CT. New Britain, CT. Lewes, DE. Newark, DE. Boise, ID. Bloomington, IL. Canton, IL.

• Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers

  Conditions:	Liver Cancer; Anxiety Disorder; Depression; Small Cell Lung Cancer; Extrahepatic Bile Duct Cancer; Malignant Mesothelioma; Pancreatic Cancer; Esophageal Cancer; Gastric Cancer; Non-small Cell Lung Cancer
  Last Updated:	February 26, 2019
  Status:	Active, not recruiting
  Locations:	La Crosse, WI. Marshfield, WI. Milwaukee, WI. La Jolla, CA. Honolulu, HI. Chicago, IL. Evanston, IL. Glenview, IL. Highland Park, IL. Iowa City, IA.

Find Cancer Support Services in Wisconsin

Cancer support services for mesothelioma patients include patient transport, temporary housing, physical therapy and counseling. The following local services may be of help to you while you are receiving treatment for mesothelioma in Wisconsin.

Connect With a 13-Year Mesothelioma Survivor

Heather Von St. James